Amulet Capital Partners Makes Growth Investment in SSI Strategy
December 21, 2020
Amulet Capital Partners (a healthcare-focused private equity firm) made a growth equity investment in SSI Strategy Holdings LLC, a Parsippany, New Jersey-based life sciences consulting firm, to accelerate the company’s growth and expand strategic services including a new Gene Therapy Accelerator. The capital will fund team expansion, adjacent service lines and potential tuck-in acquisitions; Simon Kennedy joined SSI Strategy's board in conjunction with the investment.
- Buyers
- Amulet Capital Partners, LP
- Targets
- SSI Strategy Holdings LLC
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Clinigen Acquires SSI Strategy
November 21, 2025
Healthcare Services
Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.
-
SSI Strategy Acquires NDA Group AB
August 15, 2023
Healthcare Services
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
-
Ampersand Capital Partners Invests in Sterling Medical Devices
June 23, 2022
Medical Devices
Ampersand Capital Partners, a healthcare-focused private equity firm, made a growth equity investment in Sterling Medical Devices, a Moonachie, New Jersey-based provider of design, development and regulatory services for the medical device industry. The investment is intended to support Sterling’s continued growth and capability expansion across product development, software/electromechanical integration, and regulatory affairs.
-
SSI Strategy Acquires Fiore Healthcare Advisors
June 29, 2021
Healthcare Services
SSI Strategy, a life sciences consultancy backed by Amulet Capital Partners, has acquired Fiore Healthcare Advisors, a Boston-based pharmacovigilance and clinical research consultancy. The acquisition adds Safety Physicians and clinical research experts to SSI, expanding the company's drug safety, pharmacovigilance and clinical research capabilities for early- and mid-stage biopharma clients.
-
VSS Capital Partners Makes Growth Investment in Ambulatory Management Solutions
April 26, 2021
Healthcare Services
VSS Capital Partners completed a growth capital investment in Ambulatory Management Solutions (AMS), a Chicago-based provider of turnkey outpatient anesthesia, surgical and administrative services. The investment will support AMS's regional expansion in Northeastern Illinois and the development of a national office-based anesthesia platform.
-
VSS and Partner Investors Make Growth Investment in Podiatry Growth Partners
October 5, 2020
Healthcare Services
VSS Capital Partners led a growth investment in Podiatry Growth Partners (PGP), a St. Louis–headquartered podiatry practice management platform, to support the company's national expansion and add-on acquisition strategy. Additional investors in the financing include Compass Group Equity Partners, Siguler Guff, and SunGate Capital; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.